Explore whether DBS may be right for you. Learn how it works, how your specific symptoms respond, and what to expect. Come away ready to have an informed conversation with your care team.
DBS is a well-established surgical therapy that uses precisely placed electrodes to deliver gentle electrical pulses to specific brain regions, restoring more normal signaling in circuits disrupted by Parkinson's disease.
Using advanced MRI-guided imaging, a neurosurgeon places electrodes (leads) in the exact brain region responsible for your most disabling symptoms, typically the STN or GPi.
A small implanted pulse generator (IPG), placed under the skin near the collarbone, sends adjustable electrical pulses through the leads, working day and night.
Your neurologist fine-tunes the stimulation parameters over weeks and months to maximize benefit and minimize side effects. Programming is highly individualized.
Unlike lesioning procedures, DBS is fully adjustable and potentially reversible. Stimulation can be turned off, reprogrammed, or modified as your disease evolves.
Parkinson's Disease is a gradually progressive illness whose effects can vary significantly from one person to another and, even though it is considered a "movement disorder," it can nonetheless be associated with a variety of movement and non-movement symptoms, requiring careful, individualized treatment strategies.
In Parkinson's disease, the loss of dopamine-producing cells disrupts the basal ganglia, a group of brain structures that control movement. This creates abnormal electrical "noise" that makes smooth, voluntary movement difficult.
DBS doesn't cure Parkinson's or slow its progression. Instead, it interrupts the abnormal signaling patterns, effectively "quieting the noise" and allowing more normal movement circuits to function.
📋 The "levodopa test": If your motor symptoms improve significantly with levodopa, DBS is likely to help those same symptoms; it essentially creates a sustained "on" state. Symptoms that don't respond to levodopa generally won't improve with DBS either (with notable exceptions such as tremor, which does consistently respond to DBS).
Click each component to learn about it
↑ Click a component to learn about it
Select the symptoms you experience. The panel on the right will show you how well DBS typically addresses each one, helping you build realistic expectations.
Parkinson's disease is not one condition. Two broad subtypes are recognized, and while many patients fall somewhere in between, or shift over time, and understanding these patterns can inform both prognosis and surgical planning.
The hallmark is a prominent resting tremor, typically a rhythmic 4–6 Hz shaking of a limb at rest that partially or fully resolves with purposeful movement. Slowness and rigidity are present but relatively mild.
DBS is highly effective for tremor-dominant PD. The Vim nucleus of the thalamus provides the most robust tremor suppression. The STN is often preferred when tremor coexists with meaningful bradykinesia or off periods, as it addresses the full motor spectrum and may allow medication reduction.
The dominant features are slowness (bradykinesia), rigidity, and postural instability with gait difficulty (PIGD). Tremor may be absent or minor. This subtype tends to progress more rapidly and carries greater risk of axial and cognitive symptoms over time.
Bradykinesia, rigidity, motor fluctuations, and dyskinesias respond very well to DBS at the STN or GPi. Gait freezing and balance are less reliably improved. The GPi may be preferred when cognitive concerns are present, given its more neutral neuropsychological profile. Careful patient selection is particularly important in this subtype.
Many different factors, including medical, surgical, and personal considerations, inform whether and when DBS makes sense. Click any factor below to understand how it fits into that conversation. Because each patient's situation is unique, even a single factor can sometimes be decisive.
Select a category above, then click any factor to see how it informs DBS timing and candidacy.
The choice of brain target is one of the most important decisions in DBS planning, and it's made collaboratively between you and your care team based on your unique symptom profile.
| STN Subthalamic Nucleus ⭐ Most Widely Used | GPi Globus Pallidus internus 🧠 Cognitively Safer | Vim Ventral Intermediate Nucleus 🫨 Tremor-Dominant Only | |
|---|---|---|---|
| Tremor control | Excellent ✦✦✦ | Very good ✦✦ | Outstanding ✦✦✦ |
| Rigidity & slowness | Excellent ✦✦✦ | Very good ✦✦ | None |
| Dyskinesia control | Excellent via medication reduction | Excellent direct suppression | None |
| Medication reduction | 30–50% less levodopa | Modest often still needed | None |
| Cognitive effects | Slight risk in some | Very low risk | Very low risk |
| Mood effects | Monitor carefully | Generally favorable | Generally favorable |
| Best candidates | Younger, cognitively intact patients with full motor spectrum | Older patients, cognitive concerns, prominent dyskinesia and/or dystonia | Tremor-dominant; minimal bradykinesia or rigidity |
Not all DBS systems are identical. Three advanced capabilities distinguish current devices. Depending on a patient's diagnosis, chosen brain target, and particular symptoms, one feature set may offer meaningful advantages over another.
The device monitors brain signals in real time and automatically adjusts stimulation — increasing output when symptoms worsen and reducing it when they improve or dyskinesia appears.
Adaptive stimulation is the ability to modulate how much stimulation is being delivered based upon feedback signals from neural circuits. To do this, in addition to delivering stimulation, a DBS lead can also record local field potentials ("LFPs"), the collective electrical activity of nearby neurons. In Parkinson's disease, excess beta-band (β) oscillations (13–30 Hz) correlate with motor symptoms such as rigidity and bradykinesia. When beta power rises above a set threshold, the device increases stimulation; when it falls, stimulation is reduced. Some systems additionally detect high-frequency “gamma” (γ) oscillations (60–90 Hz) linked to dyskinesia and decrease output accordingly.
The task of the movement disorders neurologist programming an adaptive DBS system is to set the thresholds appropriately to maximize benefit and minimize over-stimulation. Adjust the sliders below to see how those changes affect the timing and duration of DBS activation.
Drag the threshold lines or use the sliders (β top, γ bottom) to adjust sensitivity.
Stimulation can be steered toward the therapeutic target and away from neighboring structures, reducing side effects and enabling personalized, image-guided programming.
Modern DBS leads contain segmented contacts arranged around the shaft. By activating individual segments, clinicians can steer the electrical field toward the therapeutic target while avoiding adjacent structures. Select a target below, then click individual contacts to see how current spreads through the anatomy.
Try DBS Targeting & Programming: Drag the lead (⊕) to reposition it.
Click a contact arc to increase stimulation intensity;
shift-click to reduce it. Select STN or GPi to snap the lead
back to that target.
Green shows how much electrical current is reaching the therapeutic target.
Red shows spread into a region that causes side effects.
The red structure shown here is the “internal capsule,” the source
of most stimulation-induced side effects such as muscle contractions and
speech difficulty.
Physicians can review device data and adjust stimulation settings without an in-person visit, enabling more frequent fine-tuning after implantation.
After implantation, DBS settings require gradual fine-tuning to achieve optimal therapeutic benefit over several visits. Remote programming capability allows an expert movement disorders neurologist to review stored data from the device and make adjustments from a distance, reducing the burden of frequent clinic visits, particularly for patients who live far from the treating center or who have difficulty with travel. Nonetheless, in-person visits remain preferred because the neurologist gets better, more-precise feedback about good and bad stimulation effects when face-to-face with the patient.
No two patients are alike, and neither are our operations. We offer three distinct surgical approaches, each employing state-of-the-art technology, tailored precisely to your anatomy, your target, and your comfort. Click any approach below to learn more, or select multiple to compare them side by side.
From evaluation to long-term care, here's a realistic timeline of what the DBS process looks like at Brown Neurosurgery.
DBS candidacy is never a single-doctor decision. Over the course of a day-long, multidisciplinary “fast-track” clinic, you’ll be evaluated by a movement disorders neurologist, neurosurgeon, neuropsychologist, physical or occupational therapist, and a speech or swallow specialist; occasionally you may also see a psychiatrist. Advanced brain imaging (MRI) confirms anatomical suitability. A formal "levodopa challenge" test may be performed.
After the multidisciplinary team has provided its recommendations, if you wish to discuss proceeding with DBS surgery, you will meet again with the neurosurgical team for an in-depth conversation about your particular risks and benefits in light of the team's assessment. This is the time to ask any remaining questions and to make a fully informed decision together.
Your neurosurgeon uses specialized software to plan the exact electrode trajectory for your unique anatomy, avoiding blood vessels and critical structures. Modern techniques use intraoperative MRI or CT guidance for real-time confirmation of lead placement accuracy.
DBS systems are implanted in either two or three stages, depending on which surgical approach is used; see Our Surgical Approach for a detailed description of each. In all cases, only the lead placement step requires an overnight hospital stay (typically one night); all other stages are outpatient procedures. The pulse generator (battery) implantation, performed under general anesthesia through two small incisions, one near the collarbone and another behind the ear to connect the extender to the leads, is a brief and straightforward procedure done as a separate outpatient visit.
Your neurologist activates the stimulator and begins systematic programming. This is an iterative process; finding the optimal stimulation parameters takes patience. Medications are also adjusted in parallel.
Benefit from DBS builds over time. Most patients see incremental improvement over the first year as programming is refined. It's important not to judge the final outcome too early, as 6–12 months is often needed to find the best settings.
DBS requires ongoing follow-up, typically every 6–12 months, for programming adjustments as the disease evolves and reprogramming needs change. If you have a non-rechargeable battery (which is often easier for patients to manage), a minor outpatient procedure is required every few years to replace the IPG. If a newer battery generation is available at that time, you may also be a candidate for an upgrade to the newest device.
Honest answers to the questions patients ask most often.
This resource was developed by the Division of Functional and Epilepsy Neurosurgery at Brown University Health to help patients and families better understand deep brain stimulation and its role in managing movement disorders and other neurological conditions. Our division cares for patients with epilepsy, movement disorders, psychiatric conditions, and other disorders of neural circuit function, offering surgical and neuromodulation approaches aimed at restoring quality of life. We hope this page supports more informed and confident conversations about your care.
